| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/05/2004 | CA2513432A1 Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist |
| 08/05/2004 | CA2512043A1 Use of n-desmethylclozapine to treat human neuropsychiatric disease |
| 08/05/2004 | CA2509456A1 Substituted alkyl amido piperidines |
| 08/04/2004 | EP1443106A1 Somatic cell derived embryonic stem cells and its differentiated cells |
| 08/04/2004 | EP1443053A1 Analgesic antitumor peptide from scorpion and method of producing it |
| 08/04/2004 | EP1443043A2 Highly selective process for the preparation of enantiomerically pure phenyl-substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives |
| 08/04/2004 | EP1443041A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof |
| 08/04/2004 | EP1442745A1 Orally administrable opioid formulations having extended duration of effect |
| 08/04/2004 | EP1442744A2 Use of EP4 receptor ligands in the treatment of, inter alia, neuropathic pain and colon cancer |
| 08/04/2004 | EP1442743A1 Medicament comprising alpha-lipoic acid, ambroxol and/or inhibitors of the angiotensin converting enzyme (ACE) for use in the treatment of neurodegenerative diseases |
| 08/04/2004 | EP1442143A2 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/04/2004 | EP1442133A2 Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4 |
| 08/04/2004 | EP1442125A2 Chimeric viral vectors for gene therapy |
| 08/04/2004 | EP1442115A2 METHODS OF ISOLATION, EXPANSION AND DIFFERENTIATION OF FETAL STEM CELLS FROM CHORIONIC VILLUS, AMNIOTIC FLUID, AND PLACENTA AND THERAPEUTIC USES THEREOF |
| 08/04/2004 | EP1442064A2 Kinases and phosphatases |
| 08/04/2004 | EP1442050A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 08/04/2004 | EP1442049A2 Substituted amino ketone compounds |
| 08/04/2004 | EP1442047A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/04/2004 | EP1442041A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease |
| 08/04/2004 | EP1442039A1 Pyrimido (4,5-b) indole derivatives |
| 08/04/2004 | EP1442037A1 Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands |
| 08/04/2004 | EP1442036A2 Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1 |
| 08/04/2004 | EP1442034A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors |
| 08/04/2004 | EP1442030A1 Thiopene- amd thiazolesulfonamides as antineoplastic agents |
| 08/04/2004 | EP1442026A1 Triazole derivatives as cyclooxygenase (cox) inhibitors |
| 08/04/2004 | EP1442025A1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 08/04/2004 | EP1442024A1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS |
| 08/04/2004 | EP1442023A1 Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 08/04/2004 | EP1442021A1 Substituted 1h-quinolin-2-one compounds |
| 08/04/2004 | EP1442019A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 08/04/2004 | EP1442017A1 Preparation of benzosuberonylpiperidine compounds |
| 08/04/2004 | EP1442008A1 Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists |
| 08/04/2004 | EP1441772A2 Polymer conjugates of protein kinase c inhibitors |
| 08/04/2004 | EP1441764A2 Antigen arrays comprising rankl for treatment of bone disease |
| 08/04/2004 | EP1441742A2 Axon repair |
| 08/04/2004 | EP1441739A1 Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder |
| 08/04/2004 | EP1441738A1 A combination product comprising melagatran and dexamethasone |
| 08/04/2004 | EP1441732A2 Thiazole derivative and pharmaceutical use thereof |
| 08/04/2004 | EP1441730A1 Hydrazono-malonitriles |
| 08/04/2004 | EP1441728A2 Modulators of the cholesterol biosynthetic pathway |
| 08/04/2004 | EP1441727A1 Depot formulations of iloperidone and a star polymer |
| 08/04/2004 | EP1441726A1 Derivatives of phenoxy-n-'4-(isothiazolidin-1,1-dioxid-2yl)pheny!-valerian- acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumors |
| 08/04/2004 | EP1441725A1 Benzimidazoles and analogues and their use as protein kinases inhibitors |
| 08/04/2004 | EP1441722A2 Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases |
| 08/04/2004 | EP1441718A2 Carbinols for the treatment of neuropathic dysfunction |
| 08/04/2004 | EP1441717A1 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog |
| 08/04/2004 | EP1441708A1 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
| 08/04/2004 | EP1441707A1 Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder |
| 08/04/2004 | EP1441704A1 Orodispersible tablet having high homogeneity and the preparation method thereof |
| 08/04/2004 | EP1441702A2 Method for treating primary insomnia |
| 08/04/2004 | EP1441701A1 Montelukast granule formulation |
| 08/04/2004 | EP1441698A1 Flashmelt oral dosage formulation |
| 08/04/2004 | EP1441635A2 Sterile, breathable patch for treating wound pain |
| 08/04/2004 | EP1337528B1 Benzothiophene derivative compounds, process of preparation and use thereof |
| 08/04/2004 | EP1296945B1 Sulfonamide derivatives |
| 08/04/2004 | EP1280806B1 THIENO 2,3-d]PYRIMIDINEDIONES AND THEIR USE AS PHARMACEUTICALS |
| 08/04/2004 | EP1278750B1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 08/04/2004 | EP1202730B1 Use of ep4 receptor ligands in the treatment of neuropathic pain |
| 08/04/2004 | EP1192131B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives |
| 08/04/2004 | EP1169054B1 Prognosis of ptp lar related diseases |
| 08/04/2004 | EP1157001B1 Oxamic acids and derivatives as thyroid receptor ligands |
| 08/04/2004 | EP1150658B1 Method for controlling liposome size |
| 08/04/2004 | EP1140021B1 Improved formulation for topical non-invasive application in vivo |
| 08/04/2004 | EP1127071B1 Compounds with growth hormone releasing properties |
| 08/04/2004 | EP1123704B1 Remedies for spinal canal stenosis |
| 08/04/2004 | EP1112262B1 Substituted gamma-phenyl-delta-lactones and analogs thereof and uses related thereto |
| 08/04/2004 | EP1091956B1 Muscarinic antagonists |
| 08/04/2004 | EP1064256B1 Bicyclo [2.2.1] heptanes and related compounds |
| 08/04/2004 | EP0934531B1 Diagnosis of spongiform encephalopathy |
| 08/04/2004 | CN1518597A Novel fibroblast growth factors |
| 08/04/2004 | CN1518559A VHH single heavy chain antibody and method for its preparation in mammal |
| 08/04/2004 | CN1518549A Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 08/04/2004 | CN1518548A Teterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-Hydroxytryptamine-6-ligands |
| 08/04/2004 | CN1518547A Heterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 08/04/2004 | CN1518543A Pyrazole derivatives and their use as protein kinase inhibitors |
| 08/04/2004 | CN1518542A Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 08/04/2004 | CN1518463A Safety shield system for prefilled syringes |
| 08/04/2004 | CN1518446A Repinotan kit |
| 08/04/2004 | CN1517337A Preparation method of ropivacaine methanesulfonate and its compound and preparation |
| 08/04/2004 | CN1517101A Natural drug-dropping sofe extract |
| 08/04/2004 | CN1517094A Monosialic acid tetrahexose ganglioside liposome complex preparation |
| 08/04/2004 | CN1160360C Oxazonaphthalone compounds for enhancing synaptic response |
| 08/04/2004 | CN1160348C Aryl-{4-fluoro-4-{(2-pyridin-2-YL-ethylamino)-methyl]-piperidin-yl}-methanone derivatives as 5-HT1 receptor antagonists |
| 08/04/2004 | CN1160343C Aminothiazole inhibitors of cyclin dependent protein kinasses of cells |
| 08/04/2004 | CN1160333C Ester of pipperidinemethanol and their use as prodrugs of the 5HT2A receptor antagonist MDL 110,907 |
| 08/04/2004 | CN1160332C N-aryloxyethylamine derivatives for treatment of depression |
| 08/04/2004 | CN1160329C O-thiocarbamoyl-aminoalkanol copmound, their pharmaceutically acceptable salt and process for preparing the same |
| 08/04/2004 | CN1160312C Substituted alkyl tetramine dervative |
| 08/04/2004 | CN1160119C Functions for Tob gene in central nervous system of mammol and its application |
| 08/04/2004 | CN1160114C Chinese meidcine composition for preventing and treating senile dementai |
| 08/04/2004 | CN1160104C Traditional chinese medicine compostion with blood-enrich, tonifying Qi and warming kidney function |
| 08/04/2004 | CN1160090C Sobering-up composition |
| 08/04/2004 | CN1160080C Use of algin oligosaccharide for preparing medicine for preventing dementia by hyoscine |
| 08/04/2004 | CN1160076C Pharmaceutical composition comprising bisphosphonic acid |
| 08/04/2004 | CN1160074C Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters |
| 08/04/2004 | CN1160072C MAG expression promoters |
| 08/04/2004 | CN1160071C Use of substiuted 2,4-imidazolidinedione compounds as analgesics |
| 08/04/2004 | CN1160065C Use of preparing medicine for treating depression by low affinity NMDA antagonists |
| 08/04/2004 | CN1160060C Compressed compositions comprising clarified xanthan gum |
| 08/04/2004 | CN1159984C Prophylactic dietary supplement based on milk |